Article
Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.
Microbial drug resistance (Larchmont, N.Y.) - 1 Jan 2016
Mendes Rodrigo E, Deshpande Lalitagauri M, Costello Andrew J, Farrell David J, Jones Ronald N, Flamm Robert K
Abstract excerpt
Baseline methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients with nosocomial and community-acquired pneumonia collected during Phase 3 trials for ceftobiprole were characterized. Eighty-four unique isolates from patients enrolled in Europe (50.0%), Asia-Western Pacific region (APAC; 20.2%), North America (19.0%), Latin America (8.3%), and South Africa (2.4%) were included. Antimicrobial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
